Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep238 | Calcium and Bone | ECE2022

Primary hyperparathyroidism and rheumatoid arthritis

Athanassiou Lambros , Kostoglou-Athanassiou Ifigenia , Mavroudi Maria , Tsakiridis Pavlos , Koukosias Nikolaos , Athanassiou Panagiotis

Rheumatoid arthritis is a systemic autoimmune inflammatory disease characterized by severe pain, if left untreated. Primary hyperparathyroidism is a systemic disorder characterized by disordered calcium metabolism leading to increased serum calcium and PTH levels. Primary hyperparathyroidism may be due to the presence of a parathyroid adenoma or parathyroid hyperplasia. The aim was to present a cohort of patients with rheumatoid arthritis who presented with primary hyperparath...

ea0063ep38 | Diabetes, Obesity and Metabolism | ECE2019

Lipid profile and cardiovascular risk in psoriatic arthritis

Kostoglou-Athanassiou Ifigenia , Kostopoulos Markos , Athanassiou Lambros , Tsakiridis Pavlos , Athanassiou Panagiotis

Introduction: Psoriatic arthritis (PsA) is a chronic systemic autoimmune disorder. Currently, various biologic agents are administered in PsA patients, improving significantly disease manifestations as well as quality of life. Biologic treatment may have an effect on lipid profile and the cardiovascular risk in the disease.Aim: The aim was to follow-up a group of PsA patients and to evaluate comorbidities, lipid profile and cardiovascular risk and the ef...

ea0070ep86 | Bone and Calcium | ECE2020

Edentulism and the management of osteoporosis

Kostoglou-Athanassiou Ifigenia , Athanassiou Lambros , Spyropoulos Panagiotis , Manta Erasmia , Tsakiridis Pavlos , Giannakopoulos Andreas , Pastroudis Alexandros , Athanassiou Panagiotis

Complete or partial edentulism is common in middle age, especially in postmenopausal women. Edentulism may be the result of either dental problems or periodontitis or both. Periodontitis is characterized by systemic inflammation and may be accompanied by osteoporosis. Osteoporotic patients on treatment with anticatabolic agents may develop osteonecrosis of the jaw. The aim was to present the management of osteoporosis in an edentulous patient with severe periodontitis who deve...

ea0070ep89 | Bone and Calcium | ECE2020

Cortisol secreting adrenal adenoma. A clinically silent cause of osteoporosis

Kostoglou-Athanassiou Ifigenia , ATHANASSIOU Lambros , Ginis Alexandros , Manta Erasmia , Tsakiridis Pavlos , Giannakopoulos Andreas , Pastroudis Alexandros , Athanassiou Panagiotis

Adrenal adenomas are nowadays frequently diagnosed in the context of abdominal imaging. Osteoporosis may be a presenting manifestation of a cortisol producing adrenal adenoma. The aim was to present two cases of patients diagnosed and treated for osteoporosis who later in the course of the disease were diagnosed with a cortisol producing adrenal adenoma. Two patients, female aged 53 and 56 years, respectively, presented with osteoporosis. T score was −2.8 and &#...

ea0070ep130 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Similar effect of tocilizumab, an interleukin-6 receptor antagonist, administered either intravenously or subcutaneously on lipid levels in rheumatoid arthritis

Athanassiou Panagiotis , Athanassiou Lambros , Tzanavari Aikaterini , Gatsiou Marina , Devetzi Eirini , Tsakiridis Pavlos , Mavroudi Maria , Kostoglou-Athanassiou Ifigenia

Tocilizumab is an interleukin-6 receptor antagonist used in the treatment of rheumatoid arthritis (RA). It is known to induce remission and inhibit radiographic progression in RA. Tocilizumab may be administered either intravenously or subcutaneously. Its effect on lipid levels and the cardiovascular risk has not been fully investigated. The aim was to study the effect of tocilizumab administered either iv or sc on disease activity, lipid levels and cardiovascular risk in RA p...

ea0070aep429 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

The management of nonalcoholic fatty liver disease with a choline containing antioxidant compound

Athanassiou Panagiotis , Athanassiou Lambros , Kotrotsios Anastasios , Gatsiou Marina , Tsakiridis Pavlos , Devetzi Eirini , Mavroudi Maria , Kaiafa Georgia , Savopoulos Christos , Kostoglou-Athanassiou Ifigenia

Nonalcoholic fatty liver disease has an increased worldwide prevalence due to obesity and the use of various drugs affecting the liver. The pathogenesis of nonalcoholic fatty liver disease is presently not completely defined. In addition, there is a paucity of agents for its treatment. Choline deficiency has been shown to induce nonalcoholic liver disease. Systemic autoimmune rheumatic diseases require chronic systemic treatment with various agents, which may affect liver func...